Guidance for Industry on Drug-Induced Liver Injury: Premarketing Clinical Evaluation - Guidance

This Other document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder  Docket folder icon


See attached file(s)



Guidance for Industry on Drug Induced Liver Injury Premarketing Clinical Evaluation Guidance

View Attachment:
Authors: drug-induced; liver-injury

ID: FDA-2008-D-0128-0005

Document Information

Date Posted: Jul 30, 2009
Show More Details  


Comments Received*

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.